Nurse Practitioner, Family · Detroit, MI
NPI
1235582214
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3031 W Grand Blvd
Detroit, MI, 48202
Phone (313) 916-2600
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
328 services
Medicare patients, 2024
106
Average age 71
Drug cost, 2024
$835K
1,444 prescriptions
Company payments, 2024
$7,494
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jennifer E Pierce was code 99214 (office e&m - established), 163 times for 96 patients. In total Jennifer E Pierce billed 328 services in 8 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 163 | 96 | $62.38 | $10K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 77 | 59 | $9.96 | $767 |
| 95251 Test - Miscellaneous | Office | 70 | 44 | $21.73 | $1,521 |
By year: 2022 $15K for 252 services; 2023 $11K for 245 services; 2024 $14K for 328 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer E Pierce prescribed most often to Medicare patients was Lantus Solostar (Insulin Glargine,hum.Rec.Anlog), with 177 prescriptions and refills. In total Jennifer E Pierce wrote 1,444 Medicare prescriptions that cost $835K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 177 | 436 | 70 | $27K |
| Ozempic Semaglutide | 113 | 220 | 43 | $196K |
| Jardiance Empagliflozin | 82 | 199 | 30 | $110K |
| Metformin Hcl Generic | 78 | 208 | 35 | $747 |
| Novolog Flexpen Insulin Aspart | 77 | 205 | 36 | $19K |
| Metformin Hcl Er Metformin Hcl | 68 | 183 | 25 | $806 |
| Mounjaro Tirzepatide | 61 | 92 | 19 | $91K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 55 | 158 | 25 | $8,066 |
| Baqsimi Glucagon | 54 | 54 | 39 | $27K |
| Trulicity Dulaglutide | 50 | 113 | 19 | $110K |
| Humalog Kwikpen U-100 Insulin Lispro | 41 | 141 | 22 | $13K |
| Tresiba Flextouch U-100 Insulin Degludec | 38 | 114 | 16 | $24K |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 37 | 108 | 19 | $6,208 |
| Alendronate Sodium Generic | 36 | 65 | Under 11 | $357 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 32 | 72 | Under 11 | $3,385 |
Brand drugs: 947 claims; generic drugs: 293 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Jennifer E Pierce $7,494 ($7,494 in general payments such as food, travel and fees) from 2 companies. The largest payer was Medtronic, Inc. with $7,470.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.